ODDB.org: Open Drug Database

Swissmedic Registration	68380	Date of registration	20.01.2022
Company name	Janssen-Cilag AG	Revision date
		Valid until	01.05.2029
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Rybrevant 350 mg/7 ml	Konzentrat zur Herstellung einer Infusionslösung	Concentrate for infusion (Amivantamabum 350mg / 7ml)	L01FX18

2025	©ywesee GmbH